ICT 111Alternative Names: Cancer stem cell antigen vaccine; ICT-111
Latest Information Update: 16 Dec 2013
At a glance
- Originator ImmunoCellular Therapeutics
- Class Cancer vaccines; Dendritic cell vaccines
- Mechanism of Action Immunostimulants; Stem cell inhibitors
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Discontinued Glioblastoma